Technetium-labeled DANOFLOXACIN (cas 112398-08-0) complex as a model for infection imaging
-
Add time:07/20/2019 Source:sciencedirect.com
DANOFLOXACIN (cas 112398-08-0), a fluoroquinolone derivative antibiotic, was synthesized, successfully labeled with technetium-99m and formulated for the development of a potential diagnostic imaging agent of the bacterial infection and inflammation with higher efficiency than that of the commercially available 99mTc-ciprofloxacin. Factors affecting the labeling yield were optimized. The radiolabeled antibiotic was subjected to preclinical assessments such as purity, stability, and pharmacokinetic investigations in animals. The biodistribution studies indicated that the uptake of 99mTc-danofloxacin was high in the infectious lesion (T/NT = 7.2 ± 0.1) at 2 h post injection. The abscess to normal ratio indicated that the danofloxacin tracer can be used for infection diagnosis. The radiolabeled compound was cleared quickly from most of the body organs. The results displayed that 99mTc-danofloxacin could not differentiate between infection and sterile inflammation.
We also recommend Trading Suppliers and Manufacturers of DANOFLOXACIN (cas 112398-08-0). Pls Click Website Link as below: cas 112398-08-0 suppliers
Prev:The regulation effects of DANOFLOXACIN (cas 112398-08-0) on pig immune stress induced by LPS
Next:Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The regulation effects of DANOFLOXACIN (cas 112398-08-0) on pig immune stress induced by LPS07/21/2019
- DANOFLOXACIN (cas 112398-08-0) depletion from muscle plus skin tissue of European sea bass (Dicentrarchus labrax) fed DANOFLOXACIN (cas 112398-08-0) mesylate medicated feed in seawater at 16 °C and 27 °C07/19/2019